Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, announced on May 23 that 12 studies featuring its AI-powered digital pathology solution will be presented at the 2025 American Society of Clinical Oncology...

SimonMed Imaging and Lunit: A Major Leap Forward in Patient Health and the Future of Mammography PHOENIX, April 23, 2025 /PRNewswire/ -- SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the...

SEOUL, South Korea, April 22, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of seven posters at the American Association for...

Lunit: AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical settings and helping overcome barriers to molecular testing in NSCLC SEOUL, South Korea, March 26,...

Lunit, a Korean AI company specializing in medical imaging and diagnostics, said it has partnered with the Society for Immunotherapy of Cancer (SITC) to offer its AI-powered biomarker discovery platform to SITC-affiliated researchers. The...

Lunit: Newly published study in collaboration with Japan's NCCHE reveals how AI-powered HER2 and tumor microenvironment analysis improves patient stratification and clinical outcome predictions SEOUL, South Korea, Jan. 23,...